<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362939">
  <stage>Registered</stage>
  <submitdate>24/08/2012</submitdate>
  <approvaldate>29/08/2012</approvaldate>
  <actrnumber>ACTRN12612000921886</actrnumber>
  <trial_identification>
    <studytitle>dexamethasone and tramadol as additives to local anesthetics in ultrasound guided supraclavicular brachial plexus (SCBP) block and duration of analgesia.</studytitle>
    <scientifictitle>The effect of tramadol or dexamethasone added to lidocaine for a ultrasound guided supraclavicular brachial plexus (SCBP) block on the onset, duration of sensory and motor blockade and first request of analgesia.</scientifictitle>
    <utrn>U1111-1133-8023</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>analgesia after ultrasound guided nerve block</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>15 ml lidocaine 2% + 8 mg dexamethasone in single shot ultrasound guided supraclavicular brachial plexus block.</interventions>
    <comparator>comparator group: 15 ml of lidocaine 2% + 2 ml tramadol (50 mg/ml = 100 mg) in single shot ultrasound guided supraclavicular brachial plexus block

control group: 15 ml of lidocaine 2% + 2 ml saline in single shot ultrasound guided supraclavicular brachial plexus block</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Duration of postoperative analgesia:time interval between performing nerve block and the first analgesia request</outcome>
      <timepoint>1, 3, 6, 12, and 24 h</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>and proportion of patients requiring analgesic supplementation for the first 24h</outcome>
      <timepoint>24 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of sensory block was defined as the time  between local anesthetic (LA) administration and the complete offset of sensory anesthesia on each nerve by pinprick test.</outcome>
      <timepoint>hourly for 24 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of motor block was defined as the time from LA injection to score 5 of Bromage modified scale of each nerve.</outcome>
      <timepoint>hourly for 24 hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>patients undergoing upper limb wrist/hand/elbow or distal arm surgery</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>history of lung disease, obesity (body mass index &gt; 30 kg/m2), a history of chronic pain or psychiatric disorder, drug or alcohol abuse, and hypersensitivity to local anesthetics</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation was concealed by sealed opaque envelopes</concealment>
    <sequence>Simple randomisation using coin-tossing</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/09/2012</anticipatedstartdate>
    <actualstartdate>1/09/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>17/03/2014</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Tunisia</country>
      <state>tunis</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Tunisian Military Hospital</primarysponsorname>
    <primarysponsoraddress>20 Montfleury street, 1002, Tunis; Tunisia</primarysponsoraddress>
    <primarysponsorcountry>Tunisia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Tunisian Military Hospital</fundingname>
      <fundingaddress>20 Montfleury street, 1002, Tunis; Tunisia</fundingaddress>
      <fundingcountry>Tunisia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>During nerve blocks (which can control postoperative pain effectively), various drugs have been proposed in combination with local anesthetics (LA) to help reduce onset time and to prolong the duration of action and postoperative analgesia. Clonidine, epinephrine, and opioids are such examples but they are not without side effects.

Tramadol and dexamethasone was proposed as safe adjuvents to LA but there were no study comparing those two molecules in ultrasound guided (US) peripheral nerve blocks.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>tunisian military hospital local ethic comittee</ethicname>
      <ethicaddress>20 Montfleury street, 1002, Tunis; Tunisia</ethicaddress>
      <ethicapprovaldate>25/08/2012</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>15/08/2012</ethicsubmitdate>
      <ethiccountry>Tunisia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>trabelsi walid</name>
      <address>departement of anesthesia and intensive care unit,Tunisian Military Hospital, 20 Montfleury street ,1002 Tunis; Tunisia</address>
      <phone>+2162409193</phone>
      <fax />
      <email>walid_trabelsi2009@yahoo.fr</email>
      <country>Tunisia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>trabelsi walid</name>
      <address>departement of anesthesia and intensive care unit,Tunisian Military Hospital, 20 Montfleury street ,1002 Tunis; Tunisia</address>
      <phone>+216 2409193</phone>
      <fax />
      <email>walid_trabelsi2009@yahoo.fr</email>
      <country>Tunisia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Trabelsi walid</name>
      <address>departement of anesthesia and intensive care unit, Tunisian Military Hospital, 20 Montfleury street 1002 Tunis; TUNISIA</address>
      <phone>+21624091983</phone>
      <fax />
      <email>walid_trabelsi2009@yahoo.fr</email>
      <country>Tunisia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>